Combination of anti-PD-1 inhibitors with radiotherapy for recurrent/metastatic squamous cell carcinoma in the head and neck region

被引：0
|
作者：
Tamaskovics, Balint [1 ]
Haussmann, Jan [1 ]
Neuwahl, Judith [1 ]
Jazmati, Danny [1 ]
Plettenberg, Christian [2 ]
Althaus, Laurenz [2 ]
Boelke, Edwin [1 ]
Matuschek, Christiane [1 ]
Budach, Wilfried [1 ]
机构：
[1] Univ Klinikum Dusseldorf, Klin Strahlentherapie & Radioonkol, Dusseldorf, Germany
[2] Univ Klinikum Dusseldorf, Klin Hals Nasen Ohrenheilkunde, Dusseldorf, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P22-12
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [31] PD-L1 expression in recurrent head and neck squamous cell carcinoma
    Alice Delafoy
    Arnaud Uguen
    Gilles Lemasson
    Virginie Conan-Charlet
    Olivier Pradier
    François Lucia
    Ulrike Schick
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 343 - 351
  • [32] Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy
    Koukourakis, Ioannis M.
    Giakzidis, Axiotis G.
    Kouroupi, Maria
    Giatromanolaki, Alexandra
    Abatzoglou, Ioannis
    Karpouzis, Antonios
    Koukourakis, Michael, I
    BJR CASE REPORTS, 2021, 7 (03):
  • [33] Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy
    Hwang, Victoria
    Mendez, Eduardo
    Chow, Laura Q. M.
    Futran, Neal David
    Andersen, Peter
    Li, Ryan
    Divi, Vasu
    Rodriguez, Cristina P.
    LARYNGOSCOPE, 2019, 129 (12): : E428 - E433
  • [34] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [35] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [36] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [37] Therapeutic perspectives for recurrent or metastatic head and neck squamous cell carcinoma
    Gauduchon, Thibault
    Neidhardt, Eve Marie
    Fayette, Jerome
    CURRENT OPINION IN ONCOLOGY, 2025, 37 (03) : 175 - 183
  • [38] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [39] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
    Mirabile, Aurora
    Miceli, Rosalba
    Calderone, Rosa Gioia
    Locati, Laura
    Bossi, Paolo
    Bergamini, Cristiana
    Granata, Roberta
    Perrone, Federica
    Mariani, Luigi
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
  • [40] Prognostic Factors in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Rosko, A.
    Heft-Neal, M. E.
    Shuman, A.
    Brenner, J. C.
    Worden, F.
    Spector, M. E.
    Swiecicki, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1177 - 1177
12345